Biogen Idec, Inc. (Massachusetts) Release: US and EU Regulatory Authorities Accept Oral BG-12 Marketing Applications for Review

WESTON, Mass.--(BUSINESS WIRE)--Today Biogen Idec (NASDAQ: BIIB) announced that U.S. and EU regulatory authorities have accepted the companys marketing applications for the review of BG-12 (dimethyl f…
Read the full story: BioSpace.com Featured News